Phase II trial of a single weekly intravenous dose of Ranpirnase in patients with unresectable malignant mesotheliomaMIKULSKI, Stanislaw M; COSTANZI, John J; SHOGEN, Kuslima et al.Journal of clinical oncology. 2002, Vol 20, Num 1, pp 274-281, issn 0732-183XArticle

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a southwest oncology group studyRIVKIN, Saul E; GREEN, Stephanie J; LEW, Danika et al.Cancer. 2003, Vol 97, Num 1, pp 21-29, issn 0008-543X, 9 p.Conference Paper